Chu, N R <br/><br/>
Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7.  [electronic resource] 

 -  Cell stress & chaperones  Nov 2000 
 - 401-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1355-8145 
<br/><br/><label>Standard No.: </label>10.1379/1466-1268(2000)005<0401:ioahpt>2.0.co;2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--pharmacology<br/>Bacterial Proteins<br/>CD4-Positive T-Lymphocytes--cytology<br/>CD8 Antigens--genetics<br/>CD8-Positive T-Lymphocytes--cytology<br/>Chaperonin 60<br/>Chaperonins--genetics<br/>Female<br/>Gene Expression--immunology<br/>Histocompatibility Antigens Class II--genetics<br/>Immunotherapy--methods<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mycobacterium bovis--genetics<br/>Oncogene Proteins, Viral--genetics<br/>Papillomavirus E7 Proteins<br/>Recombinant Fusion Proteins--genetics<br/>Spleen--cytology<br/>Survival Analysis<br/>Uterine Cervical Neoplasms--immunology